Copyright
©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 222-230
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.222
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.222
Ref. | Size | Follow-up | Main findings |
Risk factors associated with vascular calcification progression in KTR | |||
Maréchal et al[56], 2012 | 281 enrolled, 197 analyzed | 4.4 yr | CAC increase: 11%/yr |
AoC increase: 4%/yr | |||
Risk factors for CAC progression: Baseline CAC, history of CVD, statin use, 25OH vit D levels | |||
Risk factors for AoC progression: Baseline AoC, higher pulse pressure, statin therapy, older age, serum phosphate level, use of aspirin, and male sex | |||
Mazzaferro et al[55], 2009 | 41 KTR compared to 31 matched dialysis patients | 2 yr | KTR blunts but does not halt CAC progression (12.2% vs 56.6% CAC progression in KTR vs dialysis patients) |
Factors associated with CAC progression: Parathyroid hormone serum levels, modality of renal replacement therapy (dialysis vs transplantation), erythrocyte sedimentation rate | |||
Seyahi et al[57], 2012 | 150 prevalent KTR without history of CVD | 2.8 yr | Baseline CAC prevalence 35.3% (mean CAC: 60 ± 174) |
Follow-up: CAC prevalence 64.4% (mean CAC: 94 ± 245) | |||
Individual CAC progression: 28%-38% | |||
Median annualized CAC progression 11 Agatston Units | |||
Factors associated with CAC progression: Baseline CAC, high triglyceride levels, biphosphonate therapy | |||
Prognostic relevance of vascular calcification in KTR | |||
Roe et al[61], 2010 | 112 asymptomatic incident KTR without history of CVD | 6 yr | Median CAC at study inception 70 (33% of patients had no CAC) |
CAC was associated with increased risk of the composite endpoint of coronary artery bypass surgery, percutaneous intervention or myocardial infarction, cerebrovascular accident or peripheral arterial disease (revascularization or amputation), and all-cause mortality. Per 100 unit increase in CAC: HR = 1.05, 95%CI: 1.00-1.11; P = 0.045 | |||
Nguyen et al[62], 2010 | 281 enrolled | 2.3 yr | CAC independent predictor of the composite endpoint of cardiovascular death, myocardial infarction, stroke or transient ischemic attack and revascularization. For a 2.72 fold increase in CAC, HR = 1.40, 95%CI: 1.12-1.75, for a 2.72-fold increase in CAC, P < 0.0031 |
- Citation: D’Marco L, Bellasi A, Mazzaferro S, Raggi P. Vascular calcification, bone and mineral metabolism after kidney transplantation. World J Transplant 2015; 5(4): 222-230
- URL: https://www.wjgnet.com/2220-3230/full/v5/i4/222.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i4.222